The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...

Bausch + Lomb said enVista Envy intraocular lenses will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. The company is in the process of seeking ...

Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...

Bausch + Lomb Corp. (BLCO, BLCO.TO) announced that the U.S. Food and Drug Administration has approved the enVista Envy full range of ...

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...

The Lopez-led Asian Eye Institute announced Monday that two of its most accomplished doctors were recognized by top ...

The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.

It was quite a busy and eventful day for the company.

A special needs child from HD Kote Taluk underwent successful bilateral cataract surgery, restoring sight and hope, thanks to ...

XPANCEO Unveils Two New Smart Contact Lens Prototypes at GITEX Global 2024 | Augmented Reality and XR Industry News from Auganix.org ...